Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03580603 · ClinicalTrials.gov registry record · NA

Clinical Decision Support Tools for Antibiotic Prescribing

A NA study of Infectious Disease, sponsored by Beth Israel Deaconess Medical Center.

Completed
Registry status
NA
Development phase
273
Enrollment target
1
Study location

NCT03580603 is a NA study of Infectious Disease that has completed, run by Beth Israel Deaconess Medical Center. The registered enrollment target is 273 participants, below the 7,010-participant average among 18 other Infectious Disease trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03580603, a NA study of Infectious Disease, has completed, sponsored by Beth Israel Deaconess Medical Center.

COMPLETED
Registry status
NA
Development phase
273 participants
Enrollment target
1
Study location

Study Summary

The goal of this study is to assess the utility of a data visualization tool for providers' understanding patients' past microbiological culture sensitivities. Providers that are ordering antibiotics for patients with previous culture data in the medical record will be asked to answer questions regarding past sensitivity results. They will be randomized to either using the visualization tool before answering the questions or using the standard medical record tools. They will then be surveyed about their decision-making, knowledge, and the usefulness of the tool.

Conditions Studied

Interventions

  • OTHER Visualization tool

Study Locations (1)

Massachusetts

  • Beth Israel Deaconess Medical Center - Boston

Trial Details

FieldValue
Enrollment Target 273 participants
Start Date 2018-03-05
Est. Completion 2018-09-30
Phase NA

What the Registry Record Tells You About NCT03580603

The ClinicalTrials.gov registry entry for NCT03580603 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 273 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 7,010-participant average among 18 other Infectious Disease trials with a reported enrollment target (96% lower). The listed sponsor is Beth Israel Deaconess Medical Center, which has 488 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Infectious Disease appearing as the primary indexed condition, and to 1 intervention - of which Visualization tool is the first listed.

NCT03580603 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT03580603 about?

NCT03580603 is a clinical study titled "Clinical Decision Support Tools for Antibiotic Prescribing". The goal of this study is to assess the utility of a data visualization tool for providers' understanding patients' past microbiological culture sensitivities. Providers that are ordering antibiotics for patients with previous culture data in the medical record will be asked to answer questions rega...

What is the current status of trial NCT03580603?

This trial is currently completed. It is a NA study. The enrollment target is 273 participants. The study started on 2018-03-05. Estimated completion is 2018-09-30.

What conditions does trial NCT03580603 study?

This clinical trial studies the following conditions: Infectious Disease.

What interventions are being tested in trial NCT03580603?

The interventions under investigation include: Visualization tool (OTHER).

Who is sponsoring clinical trial NCT03580603?

This trial is sponsored by Beth Israel Deaconess Medical Center, which has 488 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03580603 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Infectious Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.